Insights - Dendreon (DNDN) surprised early on Tuesday, as shares were up nearly 9% in early trading despite disappointing third quarter sales for its Provenge treatment for … Continue Reading
Read nowInsights - KaloBios (KBIO) rose 6% in premarket trading on favorable third quarter results. The net loss for the third quarter of 2013 was $11.3 million, or $0.47 … Continue Reading
Read nowInsights - Products targeting rare diseases are getting lots of publicity following Shire Pharmaceuticals’ (SHRP) announced acquisition of ViroPharma (VRPH), a rare-disease biopharmaceutical company, for $4.2 billion. … Continue Reading
Read nowInsights - It appears that PropThink wasn’t the only firm to notice that ViroPharma’s (VPHM) third quarter results signaled the start of some very promising trends. On … Continue Reading
Read nowInsights - Salix Pharmaceuticals (SLXP) jumped nearly 18% last week on news that it agreed to acquire Santarus, Inc. (SNTS). The combined companies will be the leading … Continue Reading
Read nowInsights - The bad news keeps coming at Coronado Biosciences (CNDO), although based on recent history, the news wasn’t a major surprise. In mid-October, CNDO announced that … Continue Reading
Read nowInsights - NPS Pharmaceuticals (NPSP) shares traded down 14% on Wednesday, despite reporting strong third quarter results and raising guidance for 2013. The weakness appears to stem … Continue Reading
Read now
